Histologics Cervical Brush Biopsy Imparts Immune Response

ANAHEIM, Calif., Sept. 5, 2019 /PRNewswire/ -- A recent study published in the Journal of Reproductive Medicine in the July/August edition, 2019 demonstrated that biopsies using novel, fabric-based, single use, sterile disposable brush biopsy devices (for outer cervix and endocervical canal) resulted in an immune response in the patient after biopsy. http://bit.ly/compassionatecolposcopy The Co-Authors were Arthur Sitelman MD, Medical Director at Integrated Pathology, Phoenix Arizona, Justin Diedrich MD, Assistant Professor of Gynecology at UC Irvine School of Medicine, and Neal M. Lonky MD, MPH, Clinical Professor of Obstetrics and Gynecology at UC Irvine School of Medicine, a women's health and colposcopy expert, and CEO/Founder of Histologics LLC.  http://www.reproductivemedicine.com/toc/auto_abstract.php?id=24790

Dr. Sitelman stated, "This study enhances the correlation of pathology findings under the microscope with clinical care and follow up." 

Dr. Lonky remarked, "Clinicians want to find true cervical cancer precursors at an early treatable stage, known to be caused by infection with the Human Papilloma Virus.  We realize not all precursors advance because of the protection of a woman's immune system. This early microscopic observation of a robust immune response following frictional brush biopsy of the cervix should lead to more studies that evaluate whether pre-cancerous lesions regress from abnormal to normal over time following such biopsies, when compared with traditional sharp biopsies done with stainless steel tools." 

Dr. Sitelman added, "Ultimately, with earlier diagnosis of precancerous dysplasia and additional understanding of the immune response, the potential to maximize patient care and decrease progression to invasive malignancy will be achieved."

Histologics LLC, manufacturer of the patented Kylon® brush technology, is dedicated to providing research-proven compassionate alternatives to tissue biopsy using frictional instead of sharp incisional removal of tissue from mucosal and body surfaces. 
https://www.ncbi.nlm.nih.gov/pubmed/?term=winter+cestero+raffo 
This use recently expanded from use in women's health to use on tissue sampling and debridement of skin surface wounds.

For more information related to this study or these products, please contact Histologics LLC at 888-738-9757 or visit our websites at www.histologics.com and www.histologicswc.com.

SOURCE Histologics LLC

Related Links

http://www.histologics.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED